As insulin prices skyrocket, pharmas and PBMs faced pointed critique from the Senate HELP Committee, led by Sen. Bernie Sanders (I–VT).
Full story here.
Published by www.biospace.com
Visited 1 times, 1 visit(s) today
May 11, 2023• byQuorum Call
As insulin prices skyrocket, pharmas and PBMs faced pointed critique from the Senate HELP Committee, led by Sen. Bernie Sanders (I–VT).